Matches in Wikidata for { <http://www.wikidata.org/entity/Q105788692> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q105788692 description "clinical trial" @default.
- Q105788692 description "ensayo clínico" @default.
- Q105788692 description "ensayu clínicu" @default.
- Q105788692 description "klinisch onderzoek" @default.
- Q105788692 description "клінічне випробування" @default.
- Q105788692 description "临床试验" @default.
- Q105788692 name "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 name "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 type Item @default.
- Q105788692 label "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 label "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 prefLabel "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 prefLabel "A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction" @default.
- Q105788692 P1050 Q105788692-8B080D51-9190-43ED-B282-8BBCB3381458 @default.
- Q105788692 P1132 Q105788692-55895A80-402D-4456-8802-0C3FCA1182C2 @default.
- Q105788692 P1476 Q105788692-A2E157EB-F651-4EB4-97A3-7C9711BEED4C @default.
- Q105788692 P2899 Q105788692-F50692A7-7451-4BB1-AFBD-F3E8DBBF19E1 @default.
- Q105788692 P3098 Q105788692-23B2F489-AED4-4264-9018-D341EDE15712 @default.
- Q105788692 P31 Q105788692-316D59D4-03B2-4721-BEB1-25DDAD13710B @default.
- Q105788692 P4135 Q105788692-B2DAD1FF-1EB1-4080-9D50-11B31B416AD1 @default.
- Q105788692 P4844 Q105788692-0D6255A5-D50B-4F74-8161-426789CEC071 @default.
- Q105788692 P4844 Q105788692-87E81B15-84B1-4D3D-A187-DC24E1FBE7F7 @default.
- Q105788692 P4844 Q105788692-D79DDFDF-01F5-495D-A2D2-C439EEDE9687 @default.
- Q105788692 P4844 Q105788692-D7C6A842-9596-4040-8DCA-5C1BBA977E65 @default.
- Q105788692 P580 Q105788692-2F6A13EF-907E-4DED-8257-1C5A691C839D @default.
- Q105788692 P582 Q105788692-44F8AF98-29B6-47D1-B1DF-211B89F4E84E @default.
- Q105788692 P6099 Q105788692-431B122F-E56B-48A3-9840-1461C5E7416B @default.
- Q105788692 P6153 Q105788692-1191575C-FD18-4A95-9554-089DF426B405 @default.
- Q105788692 P6153 Q105788692-F2B496A3-D26E-4476-86AF-2EF10A4F0A0C @default.
- Q105788692 P8005 Q105788692-2840D8BB-7DDF-4BBF-9F23-DAAB57E61BFA @default.
- Q105788692 P8363 Q105788692-B5673417-A701-41DF-9EA0-A9DE636185E5 @default.
- Q105788692 P859 Q105788692-B91811A5-A17D-4802-BBED-5C304984DC74 @default.
- Q105788692 P1050 Q356033 @default.
- Q105788692 P1132 "+52" @default.
- Q105788692 P1476 "A Phase II, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) and Trastuzumab in Combination With Capecitabine and Oxaliplatin (Xelox) in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction (GEJ)" @default.
- Q105788692 P2899 "+18" @default.
- Q105788692 P3098 "NCT04661150" @default.
- Q105788692 P31 Q30612 @default.
- Q105788692 P4135 "+75" @default.
- Q105788692 P4844 Q20707748 @default.
- Q105788692 P4844 Q412616 @default.
- Q105788692 P4844 Q420207 @default.
- Q105788692 P4844 Q422327 @default.
- Q105788692 P580 "2021-03-19T00:00:00Z" @default.
- Q105788692 P582 "2022-09-15T00:00:00Z" @default.
- Q105788692 P6099 Q42824440 @default.
- Q105788692 P6153 Q30254108 @default.
- Q105788692 P6153 Q7528920 @default.
- Q105788692 P8005 Q76649614 @default.
- Q105788692 P8363 Q78089383 @default.
- Q105788692 P859 Q212646 @default.